Article
Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations
2020-10-08
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Introduction</h4> Vaccination and anti-viral therapy with nucleos(t)ide analogues (NAs) are key approaches to reducing the morbidity, mortality and transmission of hepatitis B virus (HBV) infection. However, the efficacy of these interventions may be reduced by the emergence of drug resistance-associated mutations (RAMs) and/or vaccine escape mutations (VEMs). We have assimilated data on th...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 23e976e6-ac1a-5879-b6b8-362c84a8d876
- DOI
- 10.1101/2020.10.07.329391
